Research Papers: Immunology:
DHX9 regulates production of hepatitis B virus-derived circular RNA and viral protein levels
Metrics: PDF 796 views | HTML 1530 views | ?
Kazuma Sekiba1, Motoyuki Otsuka1, Motoko Ohno1, Takahiro Kishikawa1, Mari Yamagami1, Tatsunori Suzuki1, Rei Ishibashi1, Takahiro Seimiya1, Eri Tanaka1 and Kazuhiko Koike1
1Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan
Motoyuki Otsuka, email: firstname.lastname@example.org
Keywords: HBV; cccDNA; minicircle; primary hepatocytes; digital PCR; Immunology
Received: February 28, 2018 Accepted: March 24, 2018 Published: April 20, 2018
Hepatitis B virus (HBV) infection, which is a major health concern worldwide, can lead to liver cirrhosis and hepatocellular carcinoma. Although current nucleos(t)ide analogs efficiently inhibit viral reverse transcription and viral DNA load clinically, episomal viral covalently closed circular DNA (cccDNA) minichromosomes and transcripts from cccDNA continue to be expressed over the long term. We hypothesized that, under these conditions, viral transcripts may have biological functions involved in pathogenesis. Here, we show that the host protein DExH-box helicase 9 (DXH9) is associated with viral RNAs. We also show that viral-derived circular RNA is produced during HBV replication, and the amount is increased by knockdown of the DHX9 protein, which, in turn, results in decreased viral protein levels but does not affect the levels of HBV DNA. These phenomena were observed in the HBV-producing cell culture model and HBV mini-circle model mimicking HBV cccDNA, as well as in human primary hepatocytes infected with HBV. Based on these results, we conclude that, in HBV infection, the RNA binding factor DHX9 is a novel regulator of viral circular RNA and viral protein levels.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.